Clinical Trials Browser

Phase 1 × OTHER × peginterferon alfa-2a × Clear all

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Phase 1 Withdrawn

Hemangiosarcoma

NCT05729139 2023-08-09

Cemiplimab/Peg-Interferon-α in Advanced CSCC

Phase 1 Withdrawn

Carcinoma, Squamous Cell

NCT02407080 2019-09-12

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

Phase 1 Completed

Polycythemia Vera, Thrombocythemia, Essential